Scientists found LCPI (Lung Cancer Prognostic Index, including 7 genes) could identify surgical curable lung cancer. Clinicians are able to use LCPI to define different risk groups and make the specific therapy strategies. This breaking new study published in EBioMedicine (10/30/2014) which is high quality peer review new journal supported by CELL PRESS and The LANCET. (http://www.ebiomedicine.com/article/S2352-3964%2814%2900014-0/fulltext)